Cystic fibrosis: insights from zebrafish models
Disease Models & Mechanisms · 01.07.2026 · 19 (7)
DOI: 10.1242/dmm.052856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Disease Models & Mechanisms, online erschienen am 05.08.2026. Verfasst von Sarahdja Cornélie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathogens and Host Immunity, CNRS, Inserm, Université de Montpellier, 34095 Montpellier, France. Hauptthemen laut MEDLINE: Zebrafish, Cystic Fibrosis. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Vaincre la Mucoviscidose, Cystic Fibrosis Trust.
Abstract (Originalsprache)
Cystic fibrosis (CF) is a severe, life-limiting genetic disorder caused by mutations in the CFTR gene, which lead to defective epithelial ion transport, abnormally thick mucus and multi organ dysfunction, predominantly affecting the lungs, pancreas and digestive system. Despite significant advances in patient care, the complex interplay between CFTR dysfunction, chronic infection and persistent inflammation remains a major therapeutic challenge. In this context, animal models are indispensable for elucidating the cellular and molecular mechanisms underlying CF pathogenesis and accelerating drug discovery. Here, we review the relevance of the zebrafish (Danio rerio) as a powerful and complementary preclinical model for CF research. In particular, we highlight the unique advantages of zebrafish, including its highly conserved innate immune system and optical transparency, which together enable in vivo visualization of host immune responses under CF-like conditions at subcellular resolution. We further summarize how Cftr-deficient zebrafish models have provided key insights into the increased susceptibility to CF-relevant pathogens, disease mechanisms affecting the pancreas and the reproductive system, and the deleterious neutrophil-driven inflammation that characterizes CF. Finally, we discuss the potential of the zebrafish model for the identification and validation of novel therapeutic strategies to treat infectious and inflammatory lung pathology in CF, and outline future directions to expand its translational impact in CF research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pathogens and Host Immunity, CNRS, Inserm, Université de Montpellier, 34095 Montpellier, France.
- The Bateson Centre, School of Medicine and Population Health, University of Sheffield, Sheffield S10 2TN, UK.
ORCID-Profile: Stephen A Renshaw, Audrey Bernut
Förderung
- Association Vaincre la Mucoviscidose
- Cystic Fibrosis Trust
Zitieren
APA
Cornélie, S., Yatime, L., Lutfalla, G., Renshaw, S. A., & Bernut, A. (2026). Cystic fibrosis: insights from zebrafish models. Disease Models & Mechanisms, 19(7). https://doi.org/10.1242/dmm.052856
Vancouver
Cornélie S, Yatime L, Lutfalla G, Renshaw SA, Bernut A. Cystic fibrosis: insights from zebrafish models. Disease Models & Mechanisms. 2026;19(7). doi:10.1242/dmm.052856
BibTeX
@article{Cornlie2026,
author = {Cornélie, Sarahdja and Yatime, Laure and Lutfalla, Georges and Renshaw, Stephen A and Bernut, Audrey},
title = {Cystic fibrosis: insights from zebrafish models},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {7},
doi = {10.1242/dmm.052856}
}
EUVIMED